• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样β单体在生理和病理条件下的作用。

The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions.

作者信息

Schreiner Thomas Gabriel, Schreiner Oliver Daniel, Adam Maricel, Popescu Bogdan Ovidiu

机构信息

Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iași, Romania.

Faculty of Electrical Engineering and Information Technology, Gheorghe Asachi Technical University of Iasi, 21-23 Professor Dimitrie Mangeron Blvd., 700050 Iasi, Romania.

出版信息

Biomedicines. 2023 May 10;11(5):1411. doi: 10.3390/biomedicines11051411.

DOI:10.3390/biomedicines11051411
PMID:37239082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216198/
Abstract

Amyloid beta peptide is an important biomarker in Alzheimer's disease, with the amyloidogenic hypothesis as one of the central hypotheses trying to explain this type of dementia. Despite numerous studies, the etiology of Alzheimer's disease remains incompletely known, as the pathological accumulation of amyloid beta aggregates cannot fully explain the complex clinical picture of the disease. Or, for the development of effective therapies, it is mandatory to understand the roles of amyloid beta at the brain level, from its initial monomeric stage prior to aggregation in the form of senile plaques. In this sense, this review aims to bring new, clinically relevant data on a subject intensely debated in the literature in the last years. In the first part, the amyloidogenic cascade is reviewed and the possible subtypes of amyloid beta are differentiated. In the second part, the roles played by the amyloid beta monomers in physiological and pathological (neurodegenerative) conditions are illustrated based on the most relevant and recent studies published on this topic. Finally, considering the importance of amyloid beta monomers in the pathophysiology of Alzheimer's disease, new research directions with diagnostic and therapeutic impacts are suggested.

摘要

淀粉样β肽是阿尔茨海默病的一种重要生物标志物,淀粉样蛋白生成假说作为试图解释这类痴呆症的核心假说之一。尽管进行了大量研究,但阿尔茨海默病的病因仍未完全明确,因为淀粉样β聚集体的病理性积累无法完全解释该疾病复杂的临床症状。或者说,为了开发有效的治疗方法,必须从淀粉样β在大脑层面的作用入手,从其在形成老年斑之前的初始单体阶段开始了解。从这个意义上讲,本综述旨在提供关于近年来文献中激烈讨论的一个主题的新的、与临床相关的数据。在第一部分,回顾了淀粉样蛋白生成级联反应,并区分了淀粉样β可能的亚型。在第二部分,基于关于该主题发表的最相关和最新的研究,阐述了淀粉样β单体在生理和病理(神经退行性)条件下所起的作用。最后,考虑到淀粉样β单体在阿尔茨海默病病理生理学中的重要性,提出了具有诊断和治疗意义的新研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd8/10216198/692326d2c7f2/biomedicines-11-01411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd8/10216198/692326d2c7f2/biomedicines-11-01411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd8/10216198/692326d2c7f2/biomedicines-11-01411-g001.jpg

相似文献

1
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions.淀粉样β单体在生理和病理条件下的作用。
Biomedicines. 2023 May 10;11(5):1411. doi: 10.3390/biomedicines11051411.
2
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
3
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.单体淀粉样β蛋白的生理作用及其对阿尔茨海默病治疗的意义。
Exp Neurobiol. 2022 Apr 30;31(2):65-88. doi: 10.5607/en22004.
4
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.探索针对减轻阿尔茨海默病中与淀粉样蛋白-β级联相关事件的治疗剂的潜力。
Int J Mol Sci. 2020 Oct 9;21(20):7443. doi: 10.3390/ijms21207443.
5
The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.淀粉样β纤维核形成的遗传景观能准确地区分家族性阿尔茨海默病突变。
Elife. 2021 Feb 1;10:e63364. doi: 10.7554/eLife.63364.
6
How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.膜如何引发阿尔茨海默病?神经节苷脂簇上的β淀粉样蛋白形成毒性淀粉样纤维。
Acc Chem Res. 2014 Aug 19;47(8):2397-404. doi: 10.1021/ar500127z. Epub 2014 Jul 16.
7
Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.肽、拟肽和糖肽-肽缀合物作为阿尔茨海默病淀粉样蛋白聚集抑制剂。
ACS Chem Neurosci. 2018 Jul 18;9(7):1530-1551. doi: 10.1021/acschemneuro.8b00185. Epub 2018 Jun 26.
8
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.人脑中淀粉样β肽聚集和积累的生化阶段及其与症状前和病理前阿尔茨海默病的关系。
Brain. 2014 Mar;137(Pt 3):887-903. doi: 10.1093/brain/awt362. Epub 2014 Feb 10.
9
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.非典型可溶性淀粉样β聚集体与斑块缓冲:阿尔茨海默病靶点发现的争议与未来方向
Alzheimers Res Ther. 2017 Aug 17;9(1):62. doi: 10.1186/s13195-017-0293-3.
10
localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.在阿尔茨海默病老年斑的核心处,以β-折叠构象定位人类乙酰胆碱酯酶衍生的物种。
J Biol Chem. 2019 Apr 19;294(16):6253-6272. doi: 10.1074/jbc.RA118.006230. Epub 2019 Feb 20.

引用本文的文献

1
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis.揭示甲状腺素运载蛋白的众多生理作用:治疗甲状腺素运载蛋白淀粉样变性的关键考量因素
Ann Med. 2025 Dec;57(1):2536755. doi: 10.1080/07853890.2025.2536755. Epub 2025 Jul 27.
2
Alzheimer's Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery.阿尔茨海默病:探索病理生理假说及机器学习在药物发现中的作用
Int J Mol Sci. 2025 Jan 24;26(3):1004. doi: 10.3390/ijms26031004.
3
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease.

本文引用的文献

1
CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias.阿尔茨海默病和额颞叶痴呆中的脑脊液β淀粉样蛋白42(Aβ42)及Aβ42/Aβ40比值
Diagnostics (Basel). 2023 Feb 19;13(4):783. doi: 10.3390/diagnostics13040783.
2
Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies.单体淀粉样蛋白-β在阿尔茨海默病认知表现中的作用:来自用分泌酶抑制剂和单克隆抗体进行的临床试验的见解。
Pharmacol Res. 2023 Jan;187:106631. doi: 10.1016/j.phrs.2022.106631. Epub 2022 Dec 28.
3
BACE1 Inhibitors for Alzheimer's Disease: The Past, Present and Any Future?
用于天然产物递送的鼻脑给药策略与纳米囊泡系统相结合:聚焦阿尔茨海默病中的突触可塑性
J Pharm Anal. 2024 Dec;14(12):101057. doi: 10.1016/j.jpha.2024.101057. Epub 2024 Aug 5.
4
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies.BACE 抑制剂 umibecestat 在阿尔茨海默病预防倡议 (API) 一代研究中观察到的认知恶化的逆转。
Alzheimers Dement. 2024 Nov;20(11):7745-7761. doi: 10.1002/alz.14237. Epub 2024 Sep 25.
5
The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease.成年海马神经发生与阿尔茨海默病认知障碍的关系。
Alzheimers Dement. 2024 Oct;20(10):7369-7383. doi: 10.1002/alz.14179. Epub 2024 Aug 21.
6
The effects of nitric oxide in Alzheimer's disease.一氧化氮在阿尔茨海默病中的作用。
Med Gas Res. 2024 Dec 1;14(4):186-191. doi: 10.4103/2045-9912.385939. Epub 2023 Sep 17.
7
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer's Disease: From Mechanisms to Therapeutic Impact.阿尔茨海默病中的被动抗淀粉样蛋白β免疫疗法:从机制到治疗效果
Biomedicines. 2024 May 15;12(5):1096. doi: 10.3390/biomedicines12051096.
8
Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles.阿尔茨海默病 Aβ 肽与细胞外囊泡的特异性结合。
Int J Mol Sci. 2024 Mar 26;25(7):3703. doi: 10.3390/ijms25073703.
9
Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies.基于等离子体与微流控传感技术的阿尔茨海默病超灵敏多标志物检测
Adv Sci (Weinh). 2024 Jun;11(24):e2308783. doi: 10.1002/advs.202308783. Epub 2024 Mar 20.
BACE1 抑制剂治疗阿尔茨海默病:过去、现在和未来?
Molecules. 2022 Dec 12;27(24):8823. doi: 10.3390/molecules27248823.
4
Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity.阿尔茨海默病的传染性起源:β-淀粉样蛋白作为脑抗菌免疫的一个组成部分。
PLoS Pathog. 2022 Nov 17;18(11):e1010929. doi: 10.1371/journal.ppat.1010929. eCollection 2022 Nov.
5
Amyloid Beta in Aging and Alzheimer's Disease.β淀粉样蛋白与衰老和阿尔茨海默病。
Int J Mol Sci. 2022 Oct 26;23(21):12924. doi: 10.3390/ijms232112924.
6
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019.1990 - 2019年全球、区域及国家层面阿尔茨海默病和其他痴呆症的负担
Front Aging Neurosci. 2022 Oct 10;14:937486. doi: 10.3389/fnagi.2022.937486. eCollection 2022.
7
Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease.仑卡奈单抗、阿杜卡玛单抗和加内替单抗——对不同形式的淀粉样蛋白-β的结合谱可能解释了阿尔茨海默病临床试验中的疗效和副作用。
Neurotherapeutics. 2023 Jan;20(1):195-206. doi: 10.1007/s13311-022-01308-6. Epub 2022 Oct 17.
8
New Possibilities in the Therapeutic Approach to Alzheimer's Disease.阿尔茨海默病治疗方法的新可能。
Int J Mol Sci. 2022 Aug 10;23(16):8902. doi: 10.3390/ijms23168902.
9
The Role of Human Herpesvirus 6 Infection in Alzheimer's Disease Pathogenicity-A Theoretical Mosaic.人类疱疹病毒6型感染在阿尔茨海默病致病性中的作用——理论拼图
J Clin Med. 2022 May 29;11(11):3061. doi: 10.3390/jcm11113061.
10
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.单体淀粉样β蛋白的生理作用及其对阿尔茨海默病治疗的意义。
Exp Neurobiol. 2022 Apr 30;31(2):65-88. doi: 10.5607/en22004.